5 May 2009 14:40
Proteome Sciences plc
("Proteome Sciences" or the "Company")
Holdings in Company
5 May 2009
The Company was informed on 4 May 2009 that Sanofi-Aventis Deutschland GmbH now has an interest over 9,455,024 Ordinary 1 pence shares in Proteome Sciences, being 7.12% of the issued share capital of the Company.
The total number of the Company's ordinary shares in issue is 132,803,571.
Enquiries: Proteome Sciences plc |
|
Christopher Pearce, CEO | 01932 865 065 |
James Malthouse | |
Noble & Company Limited |
|
John Llewellyn-Lloyd | 020 7763 2200 |
Sam Reynolds |